Scintipharma
Lexington,
KY
USA
Papers:
OR.73
Mucosal Immune Responses Following Radio Controlled Capsule Delivery to Human Intestines - An Open Label Clinical Trial of An Influenza Vaccine Based on Recombinant Adenovirus